TEAM

Educational qualifications

• Ph.D.Institute of Biochemistry and Biotechnology, College of Medicine, Chung-ShanMedical University, Taichung, Taiwan
• M.D. College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan

Experience

1. Professor, Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan
2. Director, Division of Pediatric Neurology, Children’s Medical Center, Taichung Veterans General Hospital, Taichung, Taiwan
3. Professor, Ministry of Education, Taiwan
4. Director, Division of Pediatric Emergency and Critical Care, Children’s Medical Center, Taichung Veterans General Hospital, Taichung, Taiwan
5. Attending Physician, Children’s Medical Center, Taichung Veterans General Hospital, Taichung, Taiwan
6. Fellowship of Pediatric Neurology,Taichung Veterans General Hospital, Taichung, Taiwan
7. Chief Resident, Department of Pediatrics, Taichung Veterans General Hospital, Taichung, Taiwan
8. Resident, Department of Pediatrics, Taichung Veterans General Hospital, Taichung, Taiwan

Areas of expertise

1. Child development
2. Pediatric epilepsy
3. Pediatric neurometabolic disorders
4. Pediatric neurocritical care
5. Pediatric neurological rare and difficult disorders
6. Pediatric neurogenetics

Professional writings

• Publications within 5 years (*: Corresponding author)
• Yang YL, Lee HF*, Chi CS, Tsai CR, Wu PY, Liu SN. Cerebellar atrophy in genetic epileptic encephalopathies: a cohort study and a systematic review. Seizure: European Journal of Epilepsy 2024; 120:41-48.
• Chi CS, Tsai CR, Lee HF*.Resolving unsolved whole-genome sequencing data in pediatric neurological disorders: a cohort study. (Chi CS and Tsai CR as co-first authors)Arch Dis Child 2024; 109: 730-735
• Lee HF*, Chi CS. Congenital disorders of glycosylation and infantile epilepsy. Epilepsy Behav 2023; 142: 109214.
• Chi CS, Tsai CR, Lee HF*. Biallelic SHQ1 variants in early infantile hypotonia and paroxysmal dystonia as the leading manifestation. (Chi CS and Tsai CR as co-first authors)Human Genet 2023; 142:1029-1041.
• Wu PY, Chi CS, Tsai CR, Yang YL, Lee HF*. Long-term outcome of pediatric patients with anti-NMDA receptor encephalitis in a single center. Children 2023; 10: 182.
• Chi CS, Lee HF*, Tsai CR. Clinico-Radiological Phenotype of UBTF c.628G>A Pathogenic Variant-Related Neurodegeneration in Childhood: A Case Report and Literature Review. Brain Sci 2022; 12: 1262.
• Lee HF, Chi CS*, Tsai CR. Intrafamilial phenotypic variability in TBC1D24-TLDc homozygous mutation-related developmental and epileptic encephalopathy. Clin Neurol Neurosurg 2022; 214: 107142.
• Trivisano M*, Muccioli L, Ferretti A, Lee HF, Chi CS, Bisulli F. Risk of SUDEP during infancy. Epilepsy Behav 2022; 131: 107896.
• Lee HF, Hsu CC, Chi CS*, Tsai CR. Genotype-phenotype dissociation in two Taiwanese children with molybdenum cofactor deficiency caused by MOCS2 mutation. Neuropediatrics 2022; 53: 200-203.
• 10. Jan SL, Fu YC, Chi CS, Lee HF, Huang FL, Wang CC, Wei HJ, Lin MC, Chen PY, Hwang B. Catecholamine-induced secondary Takotsubo syndrome in children with severe enterovirus 71 infection and acute heart failure: A 20-year experience of a single institute. Front Cardiovasc Med 2021;8:752232.
• Chinvarun Y, Huang CW, Wu Y, Lee HF, Likasitwattanakul S, Ding J, Yamamoto T. Optimal use of perampanel in Asian patients with epilepsy: Expert opinion. Ther Clin Risk Manag 2021; 17: 739-746.
• Lee HF, Chi CS*, Tsai CR. Diagnostic yield and treatment impact of whole-genome sequencing in pediatric neurological disorders. Dev Med Child Neurol 2021; 63(8):934-938.
• Lee HF, Chi CS*. Intractable epilepsy, growth failure, hypothyroidism, and cataract: rare clinical manifestations in a patient with ring chromosome 20 syndrome. Neurology Asia 2020; 25:63-66.
• Lee HF, Chi CS*, Tsai CR. Electroclinical variability of pyridoxine-dependent epilepsy caused by ALDH7A1 gene mutations in four Taiwanese children. Brain Dev 2020;42:393-401.